Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Journal of Thoracic Disease
|
June 28, 2019
Extracellular matrix proteins as circulating biomarkers for the diagnosis of non-small cell lung cancer patients
Daniela Frezzetti, Antonella De Luca, Nicola Normanno
Expert Opinion on Investigational Drugs
|
January 26, 2017
FGFR-targeted therapeutics for the treatment of breast cancer
Antonella De Luca, Daniela Frezzetti, Marianna Gallo, et al.
Expert Review of Molecular Diagnostics
|
July 16, 2019
The potential of monitoring treatment response in non-small cell lung cancer using circulating tumour cells
Marianna Gallo, Antonella De Luca, Daniela Frezzetti, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
August 23, 2018
Pharmacokinetic drug evaluation of palbociclib for the treatment of breast cancer
Antonella De Luca, Monica R Maiello, Amelia D'Alessio, et al.
Oncotarget
|
October 27, 2014
RNA-seq analysis reveals significant effects of EGFR signalling on the secretome of mesenchymal stem cells
Antonella De Luca, Cristin Roma, Marianna Gallo, et al.
Cancers
|
April 12, 2022
The EGFR Signaling Modulates in Mesenchymal Stem Cells the Expression of miRNAs Involved in the Interaction with Breast Cancer Cells
Marianna Gallo, Marianeve Carotenuto, Daniela Frezzetti, et al.
Journal of Cellular Physiology
|
November 7, 2015
Vascular Endothelial Growth Factor A Regulates the Secretion of Different Angiogenic Factors in Lung Cancer Cells
Daniela Frezzetti, Marianna Gallo, Cristin Roma, et al.
Expert Opinion on Therapeutic Targets
|
August 24, 2017
VEGF as a potential target in lung cancer
Daniela Frezzetti, Marianna Gallo, Monica R Maiello, et al.
Journal for Immunotherapy of Cancer
|
February 3, 2024
Harmonization of tumor mutation burden testing with comprehensive genomic profiling assays: an IQN Path initiative
Riziero Esposito Abate, Raffaella Pasquale, Alessandra Sacco, et al.
Expert Opinion on Investigational Drugs
|
August 5, 2014
Vandetanib as a potential treatment for breast cancer
Antonella De Luca, Amelia D'Alessio, Monica Rosaria Maiello, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Journal of Thoracic Disease
|
June 28, 2019
Extracellular matrix proteins as circulating biomarkers for the diagnosis of non-small cell lung cancer patients
Daniela Frezzetti, Antonella De Luca, Nicola Normanno
Expert Opinion on Investigational Drugs
|
January 26, 2017
FGFR-targeted therapeutics for the treatment of breast cancer
Antonella De Luca, Daniela Frezzetti, Marianna Gallo, et al.
Expert Review of Molecular Diagnostics
|
July 16, 2019
The potential of monitoring treatment response in non-small cell lung cancer using circulating tumour cells
Marianna Gallo, Antonella De Luca, Daniela Frezzetti, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
August 23, 2018
Pharmacokinetic drug evaluation of palbociclib for the treatment of breast cancer
Antonella De Luca, Monica R Maiello, Amelia D'Alessio, et al.
Oncotarget
|
October 27, 2014
RNA-seq analysis reveals significant effects of EGFR signalling on the secretome of mesenchymal stem cells
Antonella De Luca, Cristin Roma, Marianna Gallo, et al.
Cancers
|
April 12, 2022
The EGFR Signaling Modulates in Mesenchymal Stem Cells the Expression of miRNAs Involved in the Interaction with Breast Cancer Cells
Marianna Gallo, Marianeve Carotenuto, Daniela Frezzetti, et al.
Journal of Cellular Physiology
|
November 7, 2015
Vascular Endothelial Growth Factor A Regulates the Secretion of Different Angiogenic Factors in Lung Cancer Cells
Daniela Frezzetti, Marianna Gallo, Cristin Roma, et al.
Expert Opinion on Therapeutic Targets
|
August 24, 2017
VEGF as a potential target in lung cancer
Daniela Frezzetti, Marianna Gallo, Monica R Maiello, et al.
Journal for Immunotherapy of Cancer
|
February 3, 2024
Harmonization of tumor mutation burden testing with comprehensive genomic profiling assays: an IQN Path initiative
Riziero Esposito Abate, Raffaella Pasquale, Alessandra Sacco, et al.
Expert Opinion on Investigational Drugs
|
August 5, 2014
Vandetanib as a potential treatment for breast cancer
Antonella De Luca, Amelia D'Alessio, Monica Rosaria Maiello, et al.
Page
of 3